Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy

Clinical trial NCT00159250 · COMPLETED

Trial details

NCT number: NCT00159250
Sponsor: Imperial College London
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Duchenne Muscular Dystrophy

Start date: 2007-10-26
Primary completion: 2008-12-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.